Point‐of‐care screening for sickle cell disease in low‐resource settings: A multi‐center evaluation of HemoTypeSC, a novel rapid test
Open Access
- 5 October 2018
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 94 (1) , 39-45
Abstract
Sickle cell disease (SCD) is a common, life‐threatening genetic disorder that is best managed when diagnosed early by newborn screening. However, SCD is most prevalent in low‐resource regions of the world where newborn screening is rare and diagnosis at the point‐of‐care is challenging. In many such regions, the majority of affected children die, undiagnosed, before the age of 5 years. A rapid and affordable point‐of‐care test for SCD is needed. The diagnostic accuracy of HemoTypeSC, a point‐of‐care immunoassay, for SCD was evaluated in individuals who had SCD, hemoglobin C disease, the related carrier (trait) states, or a normal hemoglobin phenotype. Children and adults participated in low‐, medium‐ and high‐resource environments (Ghana [n = 383], Martinique [n = 46], and USA [n = 158]). Paired blood specimens were obtained for HemoTypeSC and a reference diagnostic assay. HemoTypeSC testing was performed at the site of blood collection, and the reference test was performed in a laboratory at each site. In 587 participants, across all study sites, HemoTypeSC had an overall sensitivity of 99.5% and specificity of 99.9% across all hemoglobin phenotypes. The test had 100% sensitivity and specificity for sickle cell anemia. Sensitivity and specificity for detection of normal and trait states were >99%. HemoTypeSC is an inexpensive (<$2 per test), accurate, and rapid point‐of‐care test that can be used in resource‐limited regions with a high prevalence of SCD to provide timely diagnosis and support newborn screening programs.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R44HL123670)
This publication has 26 references indexed in Scilit:
- Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID studyAnnals of Hematology, 2017
- Survival in adults with sickle cell disease in a high-income settingBlood, 2016
- A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of AngolaThe Journal of Pediatrics, 2015
- Characteristics of a rapid, point‐of‐care lateral flow immunoassay for the diagnosis of sickle cell diseaseAmerican Journal of Hematology, 2015
- Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimatesThe Lancet, 2013
- The inherited diseases of hemoglobin are an emerging global health burdenBlood, 2010
- The Effect of Elevated Fetal Hemoglobin on Hemoglobin A1cResultsAmerican Journal of Clinical Pathology, 2008
- Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East LondonHaematologica, 2007
- Survival of children with sickle cell diseaseBlood, 2004
- An assessment of Sickledex as an alternative to the sickling test.Journal of Clinical Pathology, 1970